343.60001 EUR
2
0.58%
Last update Nov 18, 4:21 PM CET
Main market
Day range
343.60001
343.60001
Previous close
345.60001
Open
343.60001
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
343.60
2
0.58%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024
Total reported revenue 1.9B
Cost of revenue 275.6M
Gross profit 1.6B
Operating expense
Research & development 959.8M
Selling general and admin 831.4M
Other operating expenses
Operating income -150.8M
Non operating interest income
Income 104.0M
Expense 120.9M
Other income expense -153.9M
Pretax income -321.6M
Tax provision -84.6M
Net income -237.1M
Basic EPS -2.2
Diluted EPS -2.2
Basic average shares 108.8M
Diluted average shares 108.8M
EBITDA -4.3M
Net income from continuing op. -237.1M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 6 hours 59 minutes

10:30
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CET, UTC+01:00).